Bioventus Inc expected to post earnings of 22 cents a share - Earnings Preview

Bioventus

03/08/2026 14:24

Bioventus Inc BVS.OQ BVS.O is expected to  show a rise in quarterly revenue when it reports  results on August 5 for the period ending June 30 2026
The  United States of America-based   company is expected to report a 5.4% increase in revenue to $155.64 million from $147.66 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Bioventus Inc is for earnings of 22 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Bioventus Inc is $15.00, about 13.9% above its last closing price of $13.17
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
0.10
0.10
0.15
Beat
53.8
Dec. 31 2026
0.22
0.22
0.24
Beat
10.8
Sep. 30 2025
0.11
0.12
0.15
Beat
30.4​
Jun. 30 2025
0.21
0.21
0.21
Met
0
​​Mar. 31 2025
0.05
0.02
0.08
Beat
242.9
Dec. 31 2024
0.08
0.15
Beat
80​
Sep. 30 2024
0.01
0.03
0.06
Beat
100
Jun. 30 2024
0.07
0.07
0.19
Beat
185
This summary was machine generated August 3 at 13:24 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)